176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.62%
Net income growth similar to TSM's 17.91%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
0.44%
Less D&A growth vs. TSM's 6.83%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-150.06%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-7.56%
Negative yoy SBC while TSM is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
106.64%
Well above TSM's 4.59% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
176.86%
AR growth well above TSM's 51.68%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
26.97%
Inventory growth well above TSM's 18.29%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
128.31%
A yoy AP increase while TSM is negative at -190.69%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-31.20%
Negative yoy usage while TSM is 36.10%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-758.45%
Both negative yoy, with TSM at -98.28%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
197.99%
Operating cash flow growth above 1.5x TSM's 9.52%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-67.37%
Both yoy lines negative, with TSM at -31.73%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
100.00%
Acquisition growth of 100.00% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-115.88%
Negative yoy purchasing while TSM stands at 187.16%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-5.65%
We reduce yoy sales while TSM is 54.68%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Less 'other investing' outflow yoy vs. TSM's 2067.44%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-5.83%
Both yoy lines negative, with TSM at -28.36%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-20.58%
Both yoy lines negative, with TSM at -4973.74%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
30.90%
Issuance growth of 30.90% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.